Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Consuelo Blosch"'
Autor:
Christopher L. Marsh, Consuelo Blosch, John P. McVicar, Connie L. Davis, Rachael S. Griffin, Mark H. Wener, Erik J. Novak, James D. Perkins, Darlene Barr, Allen Farrand
Publikováno v:
Transplantation. 66:1732-1735
Background. Initial doses of OKT3 are associated with a cytokine-induced acute clinical syndrome (ACS). This study assessed the safety of a recombinant human tumor necrosis factor receptor fusion protein (TNFR:Fc) given to minimize OKT3-ACS symptoms
Autor:
Neal P. Christiansen, Roberta Hanna, Joseph W. Fay, Stanley R. Frankel, Consuelo Blosch, Geoffrey P. Herzig, Maria R. Baer, Steven H. Bernstein, Cindy Jacobs
Publikováno v:
Cancer chemotherapy and pharmacology. 43(2)
Purpose: The recombinant human interleukin-1 receptor (rhu IL-1R) is a soluble truncated form of the type 1 full-length membrane-bound receptor that binds IL-1 with identical affinity to that of the membrane form. As such, it may have clinical potent
Autor:
Loretta A. Williams, Claudio Anasetti, Cindy Ippoliti, Josephine Yen, Consuelo Blosch, Philip L. Mccarthy, Margaret Harris-Bacile, Richard E. Champlin, Donna Przepiorka, Joseph W. Fay, Cindy Jacobs
Publikováno v:
Transplantation. 62(5)
Graft-versus-host disease (GVHD) is the major complication of allogeneic bone marrow transplantation. GVHD is accompanied by the release of inflammatory cytokines, including interleukin (IL)-1, and previous work has demonstrated that IL-1 participate
Autor:
Consuelo Blosch, Brian G. Feagan, Severine Vermeire, Richard Newmark, Nan Zhang, Gil Y. Melmed, Shao-Lee Lin, Remo Panaccione, Stephan R. Targan, Paul Klekotka, Yun Chon
Publikováno v:
Gastroenterology. 143:e26
Autor:
Consuelo Blosch, Darlene Barr, Christopher L. Marsh, Mark H. Wener, James D. Perkins, John P. McVicar, Erik J. Novak, Connie L. Davis, R. S. Griffin, Allen Farrand
Publikováno v:
Transplantation. 65:152
Autor:
Nataliya Chernyukhin, Consuelo Blosch, Debra Zack, Daniel J. Lovell, Carol A. Wallace, Peter McCroskery, Scott Stryker
Publikováno v:
Pediatric Rheumatology Online Journal
Pediatric Rheumatology Online Journal, Vol 8, Iss 1, p 18 (2010)
Pediatric Rheumatology Online Journal, Vol 8, Iss 1, p 18 (2010)
Background Concerns have been raised about a potential link between the use of TNF inhibitors and development of malignancy in the pediatric population. We examined the worldwide experience of etanercept use in pediatric patients and the occurrence o